SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bacil Pharma - Quaterly Results

12 Aug 2025 Evaluate
The revenue for the June 2025 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended June 2025 of Rs. 6.68 millions grew from Rs.-0.33 millions Operating profit Margin for the quarter ended June 2025 improved to 8.93% as compared to -0.33% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 10.02 0.11 9009.09 10.02 0.11 9009.09 6.61 1.31 404.58
PBIDT 8.93 -0.33 -2806.06 8.93 -0.33 -2806.06 4.08 -0.57 -815.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 8.93 -0.33 -2806.06 8.93 -0.33 -2806.06 4.08 -0.57 -815.79
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 -50.00
PBT 8.93 -0.33 -2806.06 8.93 -0.33 -2806.06 4.07 -0.59 -789.83
TAX 2.25 0.00 0.00 2.25 0.00 0.00 0.03 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00
PAT 6.68 -0.33 -2124.24 6.68 -0.33 -2124.24 4.04 -0.59 -784.75
Equity 139.70 58.90 137.18 139.70 58.90 137.18 139.70 58.90 137.18
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bacil Pharma Share Price

55.00 -1.44 (-2.55%)
21-Apr-2026 11:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.00
Dr. Reddys Lab 1222.65
Cipla 1229.95
Zydus Lifesciences 931.80
Lupin 2323.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×